Stock Price
0.68
Daily Change
0.06 9.76%
Monthly
45.16%
Yearly
603.13%
Q2 Forecast
0.50

Starpharma Holdings reported AUD417K in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Medical Developments International AUD 7.09M 4.91M Dec/2025
Mesoblast USD -7.6M 27.47M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025